Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure

Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride:... Adv Ther (2017) 34:1976–1988 DOI 10.1007/s12325-017-0584-x ORIGINAL RESEARCH Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure . . . . Elizabeth Ofili Inder Anand Richard Allen Williams Ola Akinboboye Liou Xu Gary Puckrein Received: May 19, 2017 / Published online: July 13, 2017 The Author(s) 2017. This article is an open access publication without any supporting outcome data. We ABSTRACT conducted an exploratory retrospective propensity-matched cohort study using Medi- Introduction: Based upon the findings of the care data to determine whether a survival dif- African-American Heart Failure Trial, the US ference exists between these treatments in Food and Drug Administration approved the medication-adherent patients. fixed-dose combination of isosorbide dinitrate Methods: Black Medicare beneficiaries with HF (ISDN) and hydralazine hydrochloride (HYD) were matched with Medicare Part D data to (FDC-ISDN/HYD) as a new drug for treatment of identify patients with prescriptions to heart failure (HF) in self-identified African FDC-ISDN/HYD or the off-label combinations. Americans. According to the FDA, FDC-ISDN/ Only patients with 1-year adherence levels HYD has no therapeutic equivalent. However, C80% were included in the analysis. Propen- off-label combinations of the separate generic sity-matched scoring created two http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure

Loading next page...
 
/lp/springer_journal/fixed-dose-versus-off-label-combination-of-isosorbide-dinitrate-plus-RMR00SCbGq
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0584-x
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial